Dalton Pharma Services and Boehringer Ingelheim (Canada) Ltd. Announce the Renewal of their Chemistry Services Agreement
25-Feb-2010
- Canada
Peter Pekos, President of Dalton Pharma Services, said, “The extension of our long relationship with Boehringer Ingelheim (Canada) Ltd. aligns with Dalton’s vision to support the drug development programs of leading global pharma companies. Boehringer Ingelheim’s broad commitment to research in Canada despite the world wide reductions in the research sector, demonstrates the importance of Canada as a source of creative talent.”
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.